To find the source of intrahepatic CD62L expression, flow cytometric analysis of the intrahepatic immune cell infiltrate was performed and revealed a significant increase in the number of CD62L+ cells in patients with NASH compared to controls (Figure 1D). Here, SELL is linked to metabolic dysfunction-associated steatohepatitis.